日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population

法国儿童人群从低价肺炎球菌结合疫苗过渡到20价肺炎球菌结合疫苗的成本效益分析

Fiévez, Stéphane; Ta, An; Bellier, Lucile; Blanc, Emmanuelle; El Khoury, Jessica Y; Beillat, Maud; Sabra, Ayman; Sivignon, Marine; Ilic, Aleksandar; Perdrizet, Johnna

Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires

法国镰状细胞病患病率和成本:基于 Echantillon Généraliste des Bénéficiaires 数据的真实世界分析

Beillat, Maud; Durand-Zaleski, Isabelle; Pirenne, France; Bénard, Stève; Chillotti, Louis; Galacteros, Frédéric

Modeling the public health impact of voxelotor in the management of sickle cell disease in France

在法国,对voxelotor在镰状细胞病管理中的公共卫生影响进行建模

Galacteros, Frédéric; Ethgen, Olivier; Beillat, Maud

Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam

格列齐特强化血糖控制与标准血糖控制在2型糖尿病中的成本效益分析:一项基于越南ADVANCE试验的经济分析

Nguyen-Thi, Hai-Yen; Nguyen, Nga Tq; Le, Nguyen Dang Tu; Beillat, Maud; Ethgen, Olivier

Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate

精神分裂症功能结局的多维度评估:QUALIFY 研究结果,一项阿立哌唑每月一次与帕利哌酮棕榈酸酯的头对头试验

Potkin, Steven G; Loze, Jean-Yves; Forray, Carlos; Baker, Ross A; Sapin, Christophe; Peters-Strickland, Timothy; Beillat, Maud; Nylander, Anna-Greta; Hertel, Peter; Nitschky Schmidt, Simon; Eramo, Anna; Hansen, Karina; Naber, Dieter

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

精神分裂症患者每月一次服用阿立哌唑和棕榈酸帕利哌酮对工作准备和功能的影响:QUALIFY 研究的事后分析

Potkin, Steven G; Loze, Jean-Yves; Forray, Carlos; Baker, Ross A; Sapin, Christophe; Peters-Strickland, Timothy; Beillat, Maud; Nylander, Anna-Greta; Hertel, Peter; Nitschky Schmidt, Simon; Ettrup, Anders; Eramo, Anna; Hansen, Karina; Naber, Dieter

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

与帕利哌酮棕榈酸酯相比,每月一次服用阿立哌唑可降低性功能障碍:QUALIFY 研究结果

Potkin, Steven G; Loze, Jean-Yves; Forray, Carlos; Baker, Ross A; Sapin, Christophe; Peters-Strickland, Timothy; Beillat, Maud; Nylander, Anna-Greta; Hertel, Peter; Steen Andersen, Henrik; Eramo, Anna; Hansen, Karina; Naber, Dieter

Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

一项针对精神分裂症患者的头对头临床试验中,每月一次阿立哌唑与棕榈酸帕利哌酮的药物经济学比较:一项美国分析

Sapin, Christophe; Hartry, Ann; Kamat, Siddhesh A; Beillat, Maud; Baker, Ross A; Eramo, Anna

Efficacy, tolerability, and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed treatment comparison of double-blind randomized clinical trials

每月一次注射阿立哌唑与其他长效注射抗精神病药物在精神分裂症维持治疗中的疗效、耐受性和安全性:一项双盲随机临床试验的混合治疗比较

Majer, Istvan M; Gaughran, Fiona; Sapin, Christophe; Beillat, Maud; Treur, Maarten

Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada

阿塞那平在加拿大治疗双相情感障碍的成本效益分析

Lachaine, Jean; Beauchemin, Catherine; Mathurin, Karine; Gilbert, Dominique; Beillat, Maud